Pharmacovigilance:
At Celereius CR, we put patient safety on top of everything (or) patient safety is our priority. Pharmacovigilance ensures drug safety throughout its lifecycle, from development to post-marketing. It involves continuously monitoring, detecting, assessing, understanding, and preventing adverse effects or other drug-related problems.
A well-designed strategy leveraging advanced technology can help your company ensure patient safety and minimize the risks across your drug portfolio.
Celerius CR provides flexible, scalable, and innovative solutions to your business needs, leveraging our Natural Language Processing (NLP) and AI-powered analytics platforms.
Our proprietary AI-developed platform can analyze large datasets from sources like electronic health records (EHRs), social media, and drug usage patterns to detect adverse drug reactions earlier than traditional methods. Natural Language Processing (NLP) helps sift through vast amounts of unstructured data, such as patient comments or medical reports, to identify potential safety concerns.
Our in-house-developed Predictive Analytics methods, using Machine learning models, can predict the likelihood of adverse events based on patient characteristics, genetic information, and drug interactions. This proactive approach allows for preemptive measures to mitigate risks before they manifest in broader populations.
Celerius CR Enhanced Pharmacovigilance Workflows using AI streamlines and automates pharmacovigilance processes such as case report processing, signal detection, and causality assessment. This automation reduces manual workload, speeds up analysis, and improves the overall efficiency of safety monitoring.
Our Services:
The Pharmacovigilance system master file (PSMF) for European agencies
Patient safety monitoring and AE reporting
Drug safety and PV
Life Cycle Safety and Management
